CANC Holdings
58 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.
Top 25 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INC | 5.55% | 56,219 | $11.3M |
| 2 | MERCK & CO INC | 5.18% | 73,810 | $10.5M |
| 3 | ELI LILLY & CO | 4.69% | 8,027 | $9.5M |
| 4 | COGENT BIOSCIENCES INC | 4.60% | 310,536 | $9.4M |
| 5 | NOVARTIS AG (NOVN.SW) | 3.83% | 54,070 | $7.8M |
| 6 | GENMAB A/S | 3.67% | 203,743 | $7.5M |
| 7 | ABBVIE INC | 3.55% | 26,609 | $7.2M |
| 8 | BEONE MEDICINES LTD | 3.44% | 19,239 | $7.0M |
| 9 | HALOZYME THERAPEUTICS INC | 3.22% | 59,078 | $6.5M |
| 10 | EXELIXIS INC | 3.21% | 111,710 | $6.5M |
| 11 | BRISTOL-MYERS SQUIBB CO | 3.15% | 107,353 | $6.4M |
| 12 | IOVANCE BIOTHERAPEUTICS INC | 3.00% | 472,166 | $6.1M |
| 13 | BRIDGEBIO PHARMA INC | 2.75% | 84,251 | $5.6M |
| 14 | ROCHE HOLDING AG (RHHBY) | 2.68% | 100,715 | $5.4M |
| 15 | IDEAYA BIOSCIENCES INC | 2.61% | 146,636 | $5.3M |
| 16 | JOHNSON & JOHNSON | 2.49% | 19,604 | $5.1M |
| 17 | IMMUNOME INC | 2.49% | 264,806 | $5.1M |
| 18 | CG ONCOLOGY INC | 2.45% | 79,917 | $5.0M |
| 19 | ENLIVEN THERAPEUTICS INC | 2.37% | 116,581 | $4.8M |
| 20 | ASTRAZENECA PLC (AZN.L) | 2.12% | 26,778 | $4.3M |
| 21 | ZAI LAB LTD | 2.07% | 166,228 | $4.2M |
| 22 | RELAY THERAPEUTICS INC | 2.00% | 226,656 | $4.1M |
| 23 | LEGEND BIOTECH CORP | 1.92% | 204,009 | $3.9M |
| 24 | SUMMIT THERAPEUTICS INC | 1.89% | 214,127 | $3.8M |
| 25 | ERASCA INC | 1.89% | 271,942 | $3.8M |
Sector Weights
- Healthcare: 100.00%
Country Weights
- United States: 79.72%
- Switzerland: 9.94%
- Denmark: 3.67%
- United Kingdom: 3.03%
- China: 2.07%
- Germany: 0.68%
- Singapore: 0.53%
- Other: 0.36%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.